The present invention provides aqueous Ifosfamide compositions and a
process for their preparation, in which the compositions have a reduced
toxicity over and above the concomitant use of the uroprotective agent,
Mesna. Aqueous Ifosfamide compositions can be prepared at concentrations
as high has 1,1000 mg/ml.